Evidence map›Paper›PMID 40226085›Full record

ArticleTranslational andrology and urology2025

From obesity to inflammation: emerging frontiers in prostate cancer and metabolic syndrome studies.

Xi Xu, Jinshan Xu, Hongliang Gao, Zhaoyang Sheng, Yang Xu, Shuxiong Zeng, Guanghua Chen, Zhensheng Zhang

Abstract read
In one paragraph

Article in Translational andrology and urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xi Xu *Department of Urology, First Affiliated Hospital, Naval Medical University, Shanghai, China.ORCID https://orcid.org/0009-0004-2567-616X
Jinshan Xu *Department of Urology, First Affiliated Hospital, Naval Medical University, Shanghai, China.
Hongliang Gao *Department of Urology, First Affiliated Hospital, Naval Medical University, Shanghai, China.
Zhaoyang ShengDepartment of Urology, First Affiliated Hospital, Naval Medical University, Shanghai, China.
Yang XuDepartment of Urology, First Affiliated Hospital, Naval Medical University, Shanghai, China.
Shuxiong ZengDepartment of Urology, First Affiliated Hospital, Naval Medical University, Shanghai, China.
Guanghua ChenDepartment of Urology, First Affiliated Hospital, Naval Medical University, Shanghai, China.
Zhensheng ZhangDepartment of Urology, First Affiliated Hospital, Naval Medical University, Shanghai, China.ORCID https://orcid.org/0009-0007-3617-9515

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: According to recent studies, prostate cancer (PCa) is strongly associated with metabolic syndrome (MetS). However, there has not been any bibliometric visual analysis of relevant papers. In order to acquire knowledge about research settings and possible future paths, a thorough bibliometric study of MetS-related PCa research was carried out. Methods: From January 1, 2004 to December 31, 2023, original and review publications about MetS and PCa were retrieved from the Web of Science Core Collection (WOSCC) database. Analysis of co-authorship and co-occurrence was done using VOSviewer. To find the top terms with the greatest citation burst, CiteSpace was used. Results: There were 1,296 publications on PCa and MetS in all. The analysis showed that the number of yearly scientific papers in the sector was on the rise. The three most productive nations were China, Italy, and the USA. Most papers were published in the Conclusions: The findings provide a thorough understanding of the larger context of this field of study. Future studies need to investigate PCa's metabolic processes and inflammatory mechanism. Furthermore, switching from observational research to meta-analysis offers the possibility of illness prediction and tailored therapies. These results may help researchers navigate the most recent advancements and influence the field's future paths.

Indexed as

bibliometricinflammationmetabolic syndrome (MetS)obesityProstate cancer (PCa)

Identifiers

PMID40226085
PMCPMC11986549

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.